❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Genetics ❭ Translational studies on solid tumours [Helland] ❭ Clinical trials ❭ IMPRESS-Norway

IMPRESS-Norway

– A multi-cohort phase 2 treatment clinical study investigating efficacy of approved drugs outside indication in patients with advanced cancer

  • EudraCT number: 2023-507894-16-00
  • Clinicaltrials.gov: NCT04817956
About the study
Study design
Collaborative partners
Update/publications

 

Scroll to top

Home Dept. of Cancer Genetics Translational studies on solid tumours [Helland]

  • Group members
  • Clinical trials
    • DART
    • NIPU
    • COM-IT-2
    • MATRIX-RARE
    • IMPRESS-Norway
  • Translational studies
  • Publications
  • News

Recent publications

Jabar F, Lombardi P, Torkpour A, Tafavvoghi M, Waaler PNB, Andersen S, Paulsen EE, Pøhl M, Busund LR, Donnem T, Richardsen E, Pinato DJ, Rakaee M (2026)
CellPrior-net: Prior-guided nuclei detection and classification for H&E whole-slide images
J Pathol Inform, 23, 100716
DOI 10.1016/j.jpi.2026.100716, PubMed 42835573

Schuster C, Oppedal IA, Vinnem LI, Abrahamsson EL, Barrett TM, Steinskog ESS, Giercksky Russnes HE, Helland Å (2026)
Targeted ALK inhibition achieving tumour control in metastatic melanoma: a case report
Acta Oncol, 65, 814-817
DOI 10.2340/1651-226X.2026.46424, PubMed 42820355

Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD (2026)
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70326, PubMed 42703809

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)